These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Yes-Associated Protein Mediates the Transition from Inflammation to Fibrosis in Graves' Orbitopathy. Ko J; Kim YJ; Choi SH; Lee CS; Yoon JS Thyroid; 2023 Dec; 33(12):1465-1475. PubMed ID: 37800725 [No Abstract] [Full Text] [Related]
10. Age-related elevation of HGF is driven by the reduction of fibroblast size in a YAP/TAZ/CCN2 axis-dependent manner. Xiang Y; Qin Z; Yang Y; Fisher GJ; Quan T J Dermatol Sci; 2021 Apr; 102(1):36-46. PubMed ID: 33648801 [TBL] [Abstract][Full Text] [Related]
11. Complex fibroblast response to glucocorticoids may underlie variability of clinical efficacy in the vocal folds. Nakamura R; Mukudai S; Bing R; Garabedian MJ; Branski RC Sci Rep; 2020 Nov; 10(1):20458. PubMed ID: 33235235 [TBL] [Abstract][Full Text] [Related]
12. Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function. Mia MM; Cibi DM; Ghani SABA; Singh A; Tee N; Sivakumar V; Bogireddi H; Cook SA; Mao J; Singh MK Cardiovasc Res; 2022 Jun; 118(7):1785-1804. PubMed ID: 34132780 [TBL] [Abstract][Full Text] [Related]
13. Yap/Taz Deletion in Gli Liang M; Yu M; Xia R; Song K; Wang J; Luo J; Chen G; Cheng J J Am Soc Nephrol; 2017 Nov; 28(11):3278-3290. PubMed ID: 28768710 [TBL] [Abstract][Full Text] [Related]
14. Age-Related Downregulation of CCN2 Is Regulated by Cell Size in a YAP/TAZ-Dependent Manner in Human Dermal Fibroblasts: Impact on Dermal Aging. Qin Z; He T; Guo C; Quan T JID Innov; 2022 May; 2(3):100111. PubMed ID: 35480397 [TBL] [Abstract][Full Text] [Related]
15. M2 macrophages promote subconjunctival fibrosis through YAP/TAZ signalling. Wang Y; Geng X; Guo Z; Chu D; Liu R; Cheng B; Cui H; Li C; Li J; Li Z Ann Med; 2024 Dec; 56(1):2313680. PubMed ID: 38335557 [TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic Acid and IL-6 Trans-signaling Interact via YAP/TAZ and STAT3 Signaling Pathways in Human Trabecular Meshwork Cells. Yemanyi F; Raghunathan V Invest Ophthalmol Vis Sci; 2020 Nov; 61(13):29. PubMed ID: 33216119 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis. Toyama T; Looney AP; Baker BM; Stawski L; Haines P; Simms R; Szymaniak AD; Varelas X; Trojanowska M J Invest Dermatol; 2018 Jan; 138(1):78-88. PubMed ID: 28870693 [TBL] [Abstract][Full Text] [Related]
18. SPARC-YAP/TAZ inhibition prevents the fibroblasts-myofibroblasts transformation. Du J; Qian T; Lu Y; Zhou W; Xu X; Zhang C; Zhang J; Zhang Z Exp Cell Res; 2023 Aug; 429(1):113649. PubMed ID: 37225012 [TBL] [Abstract][Full Text] [Related]
19. YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts. Qin Z; Xia W; Fisher GJ; Voorhees JJ; Quan T Cell Commun Signal; 2018 Apr; 16(1):18. PubMed ID: 29695252 [TBL] [Abstract][Full Text] [Related]
20. YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction. Mia MM; Cibi DM; Abdul Ghani SAB; Song W; Tee N; Ghosh S; Mao J; Olson EN; Singh MK PLoS Biol; 2020 Dec; 18(12):e3000941. PubMed ID: 33264286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]